Basile Edward M 4
4 · TransMedics Group, Inc. · Filed Aug 8, 2024
Insider Transaction Report
Form 4
Basile Edward M
Director
Transactions
- Sale
Common Stock
2024-08-06$150.70/sh−1,000$150,700→ 2,269 total - Sale
Common Stock
2024-08-06$149.71/sh−2,383$356,759→ 3,269 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-06−6,750→ 6,750 totalExercise: $28.12Exp: 2032-06-01→ Common Stock (6,750 underlying) - Exercise/Conversion
Common Stock
2024-08-06$28.12/sh+6,750$189,810→ 7,482 total - Sale
Common Stock
2024-08-06$148.26/sh−1,830$271,316→ 5,652 total - Sale
Common Stock
2024-08-06$151.89/sh−1,537$233,455→ 732 total
Footnotes (6)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $147.76 to $148.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $149.21 to $150.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.50 to $151.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.80 to $152.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]The option is fully vested.